These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10691691)

  • 1. Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives.
    Sall DJ; Bailey DL; Bastian JA; Buben JA; Chirgadze NY; Clemens-Smith AC; Denney ML; Fisher MJ; Giera DD; Gifford-Moore DS; Harper RW; Johnson LM; Klimkowski VJ; Kohn TJ; Lin HS; McCowan JR; Palkowitz AD; Richett ME; Smith GF; Snyder DW; Takeuchi K; Toth JE; Zhang M
    J Med Chem; 2000 Feb; 43(4):649-63. PubMed ID: 10691691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 2. Exploring interactions at the proximal (S2) binding site.
    Sall DJ; Briggs SL; Chirgadze NY; Clawson DK; Gifford-Moore DS; Klimkowski VJ; McCowan JR; Smith GF; Wikel JH
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2527-32. PubMed ID: 9873574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dibasic benzo[b]thiophene derivatives as a novel class of active site-directed thrombin inhibitors. 1. Determination of the serine protease selectivity, structure-activity relationships, and binding orientation.
    Sall DJ; Bastian JA; Briggs SL; Buben JA; Chirgadze NY; Clawson DK; Denney ML; Giera DD; Gifford-Moore DS; Harper RW; Hauser KL; Klimkowski VJ; Kohn TJ; Lin HS; McCowan JR; Palkowitz AD; Smith GF; Takeuchi K; Thrasher KJ; Tinsley JM; Utterback BG; Yan SC; Zhang M
    J Med Chem; 1997 Oct; 40(22):3489-93. PubMed ID: 9357512
    [No Abstract]   [Full Text] [Related]  

  • 4. Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of in vivo efficacy.
    Zhang M; Bailey DL; Bastian JA; Briggs SL; Chirgadze NY; Clawson DK; Denney ML; Gifford-Moore DS; Harper RW; Johnson LM; Klimkowski VJ; Kohn TJ; Lin HS; McCowan JR; Richett ME; Sall DJ; Smith AJ; Smith GF; Snyder DW; Takeuchi K; Utterback BG; Yan SC
    Bioorg Med Chem Lett; 1999 Mar; 9(5):775-80. PubMed ID: 10201846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
    Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
    Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4" side chain.
    Bastian JA; Chirgadze N; Denney ML; Gifford-Moore DS; Sall DJ; Smith GF; Wikel JH
    Bioorg Med Chem Lett; 1999 Feb; 9(3):363-8. PubMed ID: 10091685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor Xa.
    Ewing WR; Becker MR; Manetta VE; Davis RS; Pauls HW; Mason H; Choi-Sledeski YM; Green D; Cha D; Spada AP; Cheney DL; Mason JS; Maignan S; Guilloteau JP; Brown K; Colussi D; Bentley R; Bostwick J; Kasiewski CJ; Morgan SR; Leadley RJ; Dunwiddie CT; Perrone MH; Chu V
    J Med Chem; 1999 Sep; 42(18):3557-71. PubMed ID: 10479288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
    Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
    J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of selective thrombin inhibitors based on the (R)-Phe-Pro-Arg sequence.
    Danilewicz JC; Abel SM; Brown AD; Fish PV; Hawkeswood E; Holland SJ; James K; McElroy AB; Overington J; Powling MJ; Rance DJ
    J Med Chem; 2002 Jun; 45(12):2432-53. PubMed ID: 12036353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
    Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
    Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface coupling.
    Steinmetzer T; Baum B; Biela A; Klebe G; Nowak G; Bucha E
    ChemMedChem; 2012 Nov; 7(11):1965-73. PubMed ID: 22907907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa.
    Phillips GB; Buckman BO; Davey DD; Eagen KA; Guilford WJ; Hinchman J; Ho E; Koovakkat S; Liang A; Light DR; Mohan R; Ng HP; Post JM; Shaw KJ; Smith D; Subramanyam B; Sullivan ME; Trinh L; Vergona R; Walters J; White K; Whitlow M; Wu S; Xu W; Morrissey MM
    J Med Chem; 1998 Sep; 41(19):3557-62. PubMed ID: 9733480
    [No Abstract]   [Full Text] [Related]  

  • 14. Dibasic benzo[B]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 4. SAR studies on the conformationally restricted C3-side chain of hydroxybenzo[B]thiophenes.
    Takeuchi K; Kohn TJ; Sall DJ; Denney ML; McCowan JR; Smith GF; Gifford-Moore DS
    Bioorg Med Chem Lett; 1999 Mar; 9(5):759-64. PubMed ID: 10201843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.
    Ye B; Arnaiz DO; Chou YL; Griedel BD; Karanjawala R; Lee W; Morrissey MM; Sacchi KL; Sakata ST; Shaw KJ; Wu SC; Zhao Z; Adler M; Cheeseman S; Dole WP; Ewing J; Fitch R; Lentz D; Liang A; Light D; Morser J; Post J; Rumennik G; Subramanyam B; Sullivan ME; Vergona R; Walters J; Wang YX; White KA; Whitlow M; Kochanny MJ
    J Med Chem; 2007 Jun; 50(13):2967-80. PubMed ID: 17536795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis.
    Lu T; Markotan T; Coppo F; Tomczuk B; Crysler C; Eisennagel S; Spurlino J; Gremminger L; Soll RM; Giardino EC; Bone R
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3727-31. PubMed ID: 15203151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity.
    de Candia M; Fiorella F; Lopopolo G; Carotti A; Romano MR; Lograno MD; Martel S; Carrupt PA; Belviso BD; Caliandro R; Altomare C
    J Med Chem; 2013 Nov; 56(21):8696-711. PubMed ID: 24102612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin active site inhibitors: chemical synthesis, in vitro and in vivo pharmacological profile of a novel and selective agent BMS-189090 and analogues.
    Das J; Kimball SD; Reid JA; Wang TC; Lau WF; Roberts DG; Seiler SM; Schumacher WA; Ogletree ML
    Bioorg Med Chem Lett; 2002 Jan; 12(1):41-4. PubMed ID: 11738569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
    Wang G; Goyal N; Hopkinson B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.